| dc.contributor.author | Cipriani, Andrea | |
| dc.contributor.author | Cowen, Philip J | |
| dc.date.accessioned | 2018-10-23T11:48:02Z | |
| dc.date.available | 2018-10-23T11:48:02Z | |
| dc.date.issued | 2018-06 | |
| dc.identifier.citation | Cipriani, Andrea and Cowen, Philip J. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in service personnel. Lancet Psychiatry 2018-06-01, Volume 5, Issue 6, Pages 453-455 | en |
| dc.identifier.issn | 2215-0374 | |
| dc.identifier.uri | https://oxfordhealth-nhs.archive.knowledgearc.net/handle/123456789/115 | |
| dc.description | Published online at: https://doi.org/10.1016/S2215-0366(18)30170-6
Eligible users can access the full text via NHS OpenAthens at [https://www.clinicalkey.com/#!/content/journal/1-s2.0-S2215036618301706] (login required). | en |
| dc.description.abstract | Comment: This current study describes the therapeutic use of MDMA by committed experts in a specialised setting in a small group of participants, most of whom self-referred for the trial. The unmet need for better PTSD treatment, particularly in veterans and first responders, is undoubted. However, the generalisability of the benefit of MDMA-assisted psychotherapy to more mainstream psychiatry remains to be established, recalling perhaps the famous American watchword, “Will it play in Peoria?” | en |
| dc.language.iso | en | en |
| dc.subject | Veterans | en |
| dc.subject | Post-Traumatic Stress Disorder (PTSD) | en |
| dc.subject | First Responders | |
| dc.title | 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in service personnel | en |
| dc.type | Article | en |